Clinical Trial Update: Efficacy of 20% Human Albumin in Reducing Pleural Effusion After Cardiopulmonary Bypass [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether 20% human albumin reduces pleural effusion after cardiopulmonary bypass; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoalbuminemia
• Hypoxia
• Pleural Effusion

Drugs mentioned

• 20% Human Albumin Solution (human albumin)

Snippet

Sponsor: Pauls Stradins Clinical University Hospital | Conditions: Pleural Effusions Post Coronary Artery Bypass Graft, Hypoxia | Phase 4 | Status: COMPLETED